Avila MT - Search Results

1

Dihydropyrimidinase-related protein 2 (DRP-2) gene and association to deficit and nondeficit schizophrenia.

Hong LE, Wonodi I, Avila MT, Buchanan RW, McMahon RP, Mitchell BD, Stine OC, Carpenter WT Jr, Thaker GK. Hong LE, et al. Among authors: avila mt. Am J Med Genet B Neuropsychiatr Genet. 2005 Jul 5;136B(1):8-11. doi: 10.1002/ajmg.b.30181. Am J Med Genet B Neuropsychiatr Genet. 2005. PMID: 15858820

2

Components of the smooth pursuit function in deficit and nondeficit schizophrenia.

Hong LE, Avila MT, Adami H, Elliot A, Thaker GK. Hong LE, et al. Among authors: avila mt. Schizophr Res. 2003 Sep 1;63(1-2):39-48. doi: 10.1016/s0920-9964(02)00388-2. Schizophr Res. 2003. PMID: 12892856

3

Naltrexone treatment of tardive dyskinesia in patients with schizophrenia.

Wonodi I, Adami H, Sherr J, Avila M, Hong LE, Thaker GK. Wonodi I, et al. J Clin Psychopharmacol. 2004 Aug;24(4):441-5. doi: 10.1097/01.jcp.0000132440.27854.44. J Clin Psychopharmacol. 2004. PMID: 15232337 Clinical Trial.

4

Specific motion processing pathway deficit during eye tracking in schizophrenia: a performance-matched functional magnetic resonance imaging study.

Hong LE, Tagamets M, Avila M, Wonodi I, Holcomb H, Thaker GK. Hong LE, et al. Biol Psychiatry. 2005 Apr 1;57(7):726-32. doi: 10.1016/j.biopsych.2004.12.015. Biol Psychiatry. 2005. PMID: 15820229

5

Neurophysiological markers of vulnerability to schizophrenia: sensitivity and specificity of specific quantitative eye movement measures.

Avila MT, McMahon RP, Elliott AR, Thaker GK. Avila MT, et al. J Abnorm Psychol. 2002 May;111(2):259-67. J Abnorm Psychol. 2002. PMID: 12003448

6

Current progress in schizophrenia research. Eye movement abnormalities in schizophrenia: what is the nature of the deficit?

Avila MT, Hong E, Thaker GK. Avila MT, et al. J Nerv Ment Dis. 2002 Jul;190(7):479-80. doi: 10.1097/01.NMD.0000022450.48639.D3. J Nerv Ment Dis. 2002. PMID: 12142851 No abstract available.

7

Using neurophysiological markers of genetic risk to define the boundaries of the schizophrenia spectrum phenotype.

Avila MT, Adami HM, McMahon RP, Thaker GK. Avila MT, et al. Schizophr Bull. 2003;29(2):299-309. doi: 10.1093/oxfordjournals.schbul.a007006. Schizophr Bull. 2003. PMID: 14552505

8

Neurodevelopmental interactions conferring risk for schizophrenia: a study of dermatoglyphic markers in patients and relatives.

Avila MT, Sherr J, Valentine LE, Blaxton TA, Thaker GK. Avila MT, et al. Schizophr Bull. 2003;29(3):595-605. doi: 10.1093/oxfordjournals.schbul.a007031. Schizophr Bull. 2003. PMID: 14609252

9

Catechol O-methyltransferase polymorphism and eye tracking in schizophrenia: a preliminary report.

Thaker GK, Wonodi I, Avila MT, Hong LE, Stine OC. Thaker GK, et al. Among authors: avila mt. Am J Psychiatry. 2004 Dec;161(12):2320-2. doi: 10.1176/appi.ajp.161.12.2320. Am J Psychiatry. 2004. PMID: 15569909

10

Response to unexpected target changes during sustained visual tracking in schizophrenic patients.

Hong LE, Avila MT, Thaker GK. Hong LE, et al. Among authors: avila mt. Exp Brain Res. 2005 Aug;165(1):125-31. doi: 10.1007/s00221-005-2276-z. Epub 2005 May 10. Exp Brain Res. 2005. PMID: 15883805

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters